Schizophrenia/Psychosis

This new FDA order now allows patients who need and want ECT, as well as practitioners who perform it, to breathe a sigh of relief.

Current trials are investigating adjunctive monoclonal antibody immunotherapy in schizophrenia. Take the quiz and learn more.

Promising results from a phase 2 trial of olanzapine plus samidorphan in patients with schizophrenia.

Changes in social behavior on a mobile device may indicate relapse risk that could be assessed in the clinical setting.

Recent studies and reviews report great progress in bringing TD under control.

5 questions to test your skills, based on recent findings in the literature.

Although psychotic illnesses are fortunately rare in children, contrary to common belief, psychotic symptoms can be fairly common in very young healthy children.

Cannabis continues to be the most commonly used illicit drug in the US, and the potential beneficial effects of CBD on cognition in patients with schizophrenia have critical importance.

With the prevalence of schizophrenia in older adults set to double and reach 1.1 million people in the US by 2025, greater attention to research and policy regarding this population is needed.

In this quiz, learn which medical disorders patients with schizophrenia and comorbid TD are likely to contend with.

New research considers the effects of folic acid, vitamin B6, and vitamin B12 supplementation on symptom and neurocognitive outcomes in patients with FEP.

Tardive syndromes include a broad spectrum of abnormal movements. Which movement disorders can resemble tardive dyskinesia? Find out in the quiz.

Peter F. Buckley, MD introduces part 1 of our Special Report on schizophrenia.

Two compelling case reports provide additional evidence for potential mechanistic associations between the immune system and schizophrenia.

Antipsychotic drugs are the cornerstone in the management of psychotic disorders, but most patients fail to have a “good” response in short-term trials. Alternative strategies are presented here.

Many trauma survivors do not enjoy their life due to their daily struggles with memories in the aftermath. Wounded healers are no exception. More in this Portrait of a Psychiatrist.

Are psychiatric disorders such as schizophrenia and depression triggered by infections in early life?

What factors are associated with loss of supported housing for chronically homeless patients with serious mental illnesss? Take the quiz and learn more.

Some thoughts on the pathogenesis and persistence of prevalence of schizophrenia and bipolar affective disorder in view of current discoveries.

Physical activity should be considered an important part of the management of metabolic complications in patients with psychotic disorders.

Sleep disruption is often overlooked in treatment planning for patients with psychotic disorders. Recent research provides insights in this 5-question quiz.

Given the evidence for progressive gray matter volume loss in first-episode psychosis, it is possible that leukocyte infiltration may contribute to brain tissue loss.

In some cases, treatment with antipsychotics can pose risks in women. Take the quiz and learn more.

This article provides a brief synopsis of the research regarding the use of psychotherapy to manage suicidal behavior, followed by several examples of strategies that such treatment employs.

This Special Report offers insight into gender vulnerabilities and clinical implications in areas like schizophrenia, Alzheimer dementia, and anxiety disorders.

A deep dive into how schizophrenia affects men versus women.

Consider these travel tips to help alleviate your patients’ fears that, if left unchecked, can trigger full-blown psychosis.

Tardive dyskinesia, an involuntary athetoid or choreiform movements, generally of the tongue, lower face and jaw, and extremities, is highly prevalent in patients with schizophrenia after long-term antipsychotic use. What about clozapine for TD?